Financial reports
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
ARS
2022 FY
Annual report to shareholders
5 Jun 23
10-Q
2023 Q1
Quarterly report
15 May 23
10-K/A
2022 FY
Annual report (amended)
28 Apr 23
10-K
2022 FY
Annual report
30 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
16 Aug 22
NT 10-Q
Notice of late quarterly filing
16 Aug 22
10-Q
2022 Q1
Quarterly report
19 May 22
Current reports
8-K/A
SeaStar Medical to Restate Financials, Sets Business Update Call for April 17
27 Mar 24
8-K
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
27 Mar 24
8-K
SeaStar Medical to Restate Financials, Sets Business Update Call for April 17
27 Mar 24
8-K
Other Events
8 Mar 24
8-K
FDA Grants Humanitarian Device Exemption Approval to SeaStar Medical’s Selective Cytopheretic Device for Pediatric Acute Kidney Injury
22 Feb 24
8-K
Termination of a Material Definitive Agreement
16 Feb 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
9 Feb 24
8-K
SeaStar Medical Announces Pricing of $9.0 Million Registered Direct Offering Priced At-the-Market
30 Jan 24
8-K
Other Events
24 Jan 24
8-K
Other Events
12 Jan 24
Registration and prospectus
424B3
Prospectus supplement
5 Mar 24
424B3
Prospectus supplement
5 Mar 24
424B3
Prospectus supplement
5 Mar 24
424B3
Prospectus supplement
5 Mar 24
424B3
Prospectus supplement
5 Mar 24
424B3
Prospectus supplement
5 Mar 24
424B3
Prospectus supplement
5 Mar 24
424B3
Prospectus supplement
5 Mar 24
424B3
Prospectus supplement
5 Mar 24
424B3
Prospectus supplement
5 Mar 24
Other
EFFECT
Notice of effectiveness
15 Feb 24
CORRESP
Correspondence with SEC
12 Feb 24
CORRESP
Correspondence with SEC
9 Feb 24
UPLOAD
Letter from SEC
2 Feb 24
EFFECT
Notice of effectiveness
26 Dec 23
CORRESP
Correspondence with SEC
20 Dec 23
UPLOAD
Letter from SEC
19 Dec 23
EFFECT
Notice of effectiveness
12 Dec 23
CORRESP
Correspondence with SEC
7 Dec 23
UPLOAD
Letter from SEC
6 Dec 23
Ownership